U.S. Markets open in 50 hrs, 56 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 0.88 01:02 PM EDT | |
|---|---|---|
| Day High | 0.94 09:30 AM EDT |
|
| Range | 0.06 |
| Volume | 353,975 | |
|---|---|---|
| 30-Day Avg Vol | 3.50 M |
|
| Difference | -89.91% |
| Market Cap | 42.14 M | |
|---|---|---|
| Mkt Cap Chg | -1.90 M |
| Shares Out | 47.89 M | |
|---|---|---|
| % Shrs Traded | 0.74% | |
| 1yr EPS Est | -0.257 |
| 52-Wk Low | 0.09 3/5/09 | |
|---|---|---|
| 52-Wk High | 1.58 6/8/09 |
|
| Range | 1.49 |
| Prev Close | 0.9197 7/1/09 | |
|---|---|---|
| Today's Open | 0.94 | |
| Change | 2.21% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 433,458.00 |
| Revenue (LFY) | 1.28 M | |
|---|---|---|
| Earnings (LFY) | -52.88 M | |
| Earnings (MRQ) | 451,000.00 | |
| Next Earn Est | -0.075 | |
| Next Earnings | 08/10/2009 |
|
| EPS (TTM) | -0.39 | |
| 1yr EPS Growth | 34.10% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -3.00 | |
| PEG Ratio | — | |
| Return on Equity | -239.37 | |
| Beta | 3.40 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Drugs are a life-or-death business for Keryx Biopharmaceuticals. The company specializes in developing treatments for life-threatening ailments, such as cancer and kidney disease. Its lead candidate is ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.075 8/10/09 | — — |
—
—
|
| Last Quarter | -0.08 3/31/09 | 0.01 3/31/09 |
0.09
Beat
|
| 2 Quarters Ago | -0.13 12/31/08 | -0.08 12/31/08 |
0.05
Beat
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 3.33 M | 1.28 M |
| Gross Profit | 3.30 M | 1.14 M |
| Operating Income | 344,000.00 | -38.79 M |
| Net Income | 451,000.00 | -52.88 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts